FIBROGEN INC Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Fibrogen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2024.
- Fibrogen Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.28M, a 148% decline year-over-year.
- Fibrogen Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.08M, a 26.1% increase year-over-year.
- Fibrogen Inc annual Nonoperating Income (Expense) for 2023 was $10.5M, a 38% increase from 2022.
- Fibrogen Inc annual Nonoperating Income (Expense) for 2022 was $7.6M.
- Fibrogen Inc annual Nonoperating Income (Expense) for 2021 was -$1.08M, a 119% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)